Exela Technologies, Inc. (NASDAQ:XELAP) Short Interest Update

Exela Technologies, Inc. (NASDAQ:XELAPGet Free Report) was the target of a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 3,800 shares, a growth of 46.2% from the March 31st total of 2,600 shares. Based on an average trading volume of 2,900 shares, the days-to-cover ratio is currently 1.3 days.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Exela Technologies stock. Gates Capital Management Inc. raised its stake in Exela Technologies, Inc. (NASDAQ:XELAPFree Report) by 39.5% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 46,534 shares of the company’s stock after buying an additional 13,169 shares during the period. Exela Technologies makes up about 0.0% of Gates Capital Management Inc.’s investment portfolio, making the stock its 27th largest holding. Gates Capital Management Inc.’s holdings in Exela Technologies were worth $135,000 as of its most recent filing with the SEC.

Exela Technologies Trading Up 1.4 %

NASDAQ XELAP opened at $1.82 on Monday. Exela Technologies has a 12 month low of $1.10 and a 12 month high of $5.90. The company’s 50 day simple moving average is $1.69 and its 200 day simple moving average is $1.77.

Exela Technologies Company Profile

(Get Free Report)

Exela Technologies, Inc provides transaction processing solutions, enterprise information management, document management, and digital business process services worldwide. It operates in three segments: Information & Transaction Processing Solutions (ITPS), Healthcare Solutions (HS), and Legal & Loss Prevention Services (LLPS).

Featured Articles

Receive News & Ratings for Exela Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exela Technologies and related companies with MarketBeat.com's FREE daily email newsletter.